AGEN: Rega marang dodolan Agenus, Inc.
Agenus leads in immuno-oncology, raising capital through licensing agreements and partner milestone payments. The price-to-sales ratio reflects the business valuation dynamics, where the value of 2.30 serves as the current metric. A team of top scientists is developing innovative anti-cancer agents. To mitigate the risks of platform dependency, Agenus is monetizing legacy patents by selling royalties to global pharma behemoths.
Rincian metrik lan analitis perusahaan Agenus Inc (AGEN)
- rega saham lan target rega konsensus:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
- indikator profitabilitas perusahaan lan kelipatan valuasi:
AGEN - Bathi resik|Proyeksi bathi resik Agenus|AGEN - Pangali P/E|Rasio prakiraan rega marang bathi Agenus, Inc.|AGEN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Agenus Inc|AGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Agenus|AGEN - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan agenusbio.com|AGEN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Agenus
- rincian pendapatan lan dodolan emiten:
Ringkesan analitik perusahaan:AGEN agenusbio.com
The success of Agenus (AGEN) depends on regulatory approval of new cancer immunotherapy methods and the effectiveness of partnership deals. By analyzing the historical P/S trend, an investor assesses the ratio of market capitalization to annual revenue, which allows for a real-time assessment of the market's reaction to inflationary risks and changes in margins, thereby determining the extent of the premium paid for future business growth.
Pesaing Agenus
argenx.com - Rasio kapitalisasi marang pendapatan|Multiplikator P/S BNTX (BioNTech)|Abivax Pharma (ABVX) - Rega marang dodolan|ADMA Bio - Multiplikator P/S|PTGX - Multiplikator P/S|IMVT: Multiplikator P/S|Multiplikator rega marang pendapatan kiniksa.com KNSA|GRFS (Grifols) - Multiplikator P/S|Rega marang dodolan Adaptive Biotech ADPT|Rasio rega marang pendapatan Celldex (CLDX)|Aurinia Corp - Rasio kapitalisasi marang pendapatan|BioCryst - Kapitalisasi marang pendapatan|Multiplikator P/S veratx.com VERA|DNTH - Rasio rega marang pendapatan|Koefisien rega marang pendapatan Pharvaris NV PHVS|ABCL: Multiplikator P/S|Tourmaline (TRML) - Multiplikator P/S|PGEN (Precigen, Inc.) - Multiplikator P/S|PHAR - Multiplikator rega marang pendapatan|Multiplikator P/S NKTR|UPB - Rega marang dodolan|Rasio rega marang pendapatan Zenas Biopharma, Inc. ZBIO|IMNM: Rasio kapitalisasi marang pendapatan|GOSS - Rasio rega marang pendapatan|Rasio rega marang dodolan KALV|SEPN: Multiplikator P/S|Pieris Pharma - Rasio kapitalisasi pasar marang pendapatan|SVRA (Savara Corp) - Multiplikator P/S|Multiplikator P/S Rigel Corp|Rasio rega marang pendapatan AnaptysBio, Inc. (ANAB)|ATXS (astriatx.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan enGene ENGN|RAPT - Kapitalisasi marang pendapatan|Aerovate - Multiplikator P/S|ACRS - Multiplikator P/S|KYTX (Kyverna Therapeutics) - Kapitalisasi marang pendapatan|tizianalifesciences.com - Rasio kapitalisasi pasar marang pendapatan|CABA (Cabaletta Bio) - Multiplikator P/S|Ventyx Biosciences Inc. (VTYX) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Theratechnologies Inc (THTX)|Kapitalisasi marang pendapatan Avalo Therapeutics Inc AVTX|Rasio rega marang pendapatan Eledon Pharmaceuticals ELDN|CLYM - Kapitalisasi marang pendapatan|ZURA: Kapitalisasi marang pendapatan|ATYR - Multiplikator P/S|adagene.com (ADAG) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan IMA|STTK (Shattuck Labs Inc) - Multiplikator P/S|Rega marang dodolan Equillium Bio EQ|Multiplikator P/S CNTB|Multiplikator P/S immunic-therapeutics.com (IMUX)|Multiplikator P/S ATRA (Atara Bio)|Multiplikator rega marang pendapatan InflaRx NV|X4 Pharmaceuticals - Multiplikator P/S|Rega marang dodolan Adicet Bio|celularity.com (CELU) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan INMB|Kapitalisasi marang pendapatan BRNS|Multiplikator P/S Kezar Life Sciences Inc|Rasio rega marang pendapatan SAB Biotherapeutics (SABS)|Koefisien rega marang pendapatan akaritx.com|Multiplikator P/S ENLV (Enlivex Therapeutics Ltd.)|Multiplikator P/S Q32 Bio Inc QTTB|GeoVax Labs Inc - Multiplikator P/S|Multiplikator rega marang pendapatan Edesa Biotech Corp (EDSA)|IBIO: Multiplikator P/S|Rega marang dodolan Carisma Therapeutics Inc. (CARM)|Rasio rega marang pendapatan XTL Biopharmaceuticals Ltd.|Rasio kapitalisasi marang pendapatan BOLT (Bolt Bio)|Rasio rega marang pendapatan HCW Biologics Inc. (HCWB)|APVO: Rasio rega marang dodolan|Multiplikator P/S AIM (AIM ImmunoTech Inc.)|Rasio kapitalisasi pasar marang pendapatan ADTX|GRI Bio - Multiplikator P/S|XRTX - Multiplikator P/S|ReShape Lifesciences (HIND) - Rasio rega marang pendapatan|Revelation Biosciences Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Indaptus Therapeutics|Kapitalisasi marang pendapatan scinai.com (SCNI)|Multiplikator P/S CALI|Multiplikator P/S affimed.com (AFMD)|Allakos - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOOK|IGM Bio - Multiplikator P/S|Koefisien rega marang pendapatan iteostherapeutics.com ITOS|Ocean Biomedical (OCEA) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan TC BioPharm (Holdings) Plc|Rasio rega marang pendapatan Third Harmonic Bio, Inc
